Cat allergen peptide immunotherapy reduces CD4+ T cell responses to cat allergen but does not alter suppression by CD4+ CD25 + T cells: A double-blind placebo-controlled study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 10, 2004, Pages 1097-1101

  Smith, T R F ^a   Alexander, C ^a   Kay, A B ^a   Larche M ^a   Robinson, D S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cat allergen; CD4+CD25+ T regulatory cells; Peptide immunotherapy; T cells

Indexed keywords

ALLERGEN; CORTICOSTEROID; FEL D 1 ALLERGEN; INTERLEUKIN 13; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ASTHMA; CAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ASTHMA; CATS; CD4-POSITIVE T-LYMPHOCYTES; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOUBLE-BLIND METHOD; GLYCOPROTEINS; HUMANS; INTERLEUKIN-13; MIDDLE AGED; PEPTIDES; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 4644257344     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00601.x     Document Type: Article

References (28)

1. KAY AB. Allergy and allergic diseases. N Engl J Med 2001;344:30-37.
2. ROBINSON DS. Th-2 cytokines in allergic disease. Br Med Bull 2000;56:956-968.
3. SAKAGUCHI S, SAKAGUCHI N, ASANO M, ITOH M, TODA M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164
4. SAKAGUCHI S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-458.
5. MCHUGH RS, SHEVACH EM. The role of suppressor T cells in regulation of immune responses. J Allergy Clin Immunol 2002;110:693-702.
6. MALOY KJ, POWRIE F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-822.
7. LING EM, SMITH T, NGUYEN XD, PRIDGEON C, DALLMAN MJ, ARBERY J et al. Relation of CD4 + CD25 + regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363:608-615.
8. BELLINGHAUSEN I, KLOSTERMANN B, KNOP J, SALOGA J. Human CD4 + CD25 + T cells derived from the majority of atopic donors are able to suppress Th1 and Th2 cytokine production. J Allergy Clin Immunol 2003;111:862-868.
9. DURHAM SR, TILL SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998;102:157-164.
10. VARNEY VA, GAGA M, FREW AJ, ABER VR, KAY AB, DURHAM SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-299.
11. BOUSQUET J, CALVAYRAC P, GUERIN B, HEJJAOUI A, DHIVERT H, HEWITT B et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. J Allergy Clin Immunol 1985;76:734-744.
12. VARNEY VA, EDWARDS J, TABBAH K, BREWSTER H, MAVROLEON G, FREW AJ. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Clin Exp Allergy 1997;27:860-867.
13. DURHAM SR, WALKER SM, VARGA EM, JACOBSON MR, O'BRIEN F, NOBLE W et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468-475.
14. MOORE KW, DE WAAL MALEFYT R, COFFMAN RL, O'GARRA A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
15. JUTEL M, AKDIS M, BUDAK F, AEBISCHER-CASAULTA C, WRYSZCZ M, BLASER K et al. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-1214.
16. + T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003;111:1255-1261.
17. Committee on Safety of Medicines/ Medicines Control Agency. Desensitising vaccines. BMJ 1986;293:948.
18. OLDFIELD WL, LARCHE M, KAY AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 2002;360:47-53.
19. OLDFIELD WL, KAY AB, LARCHE M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyperresponsiveness in atopic allergic asthmatic subjects. J Immunol 2001;167:1734-1739.
20. TILL S, DURHAM S, DICKASON R, HUSTON D, BUNGRE J, WALKER S et al. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression. Immunology 1997;91:53-57.
21. WILLS-KARP M, LUYIMBAZI J, XU X, SCHOFIELD B, NEBEN TY, KARP CL et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261.
22. GRUNIG G, WARNOCK M, WAKIL AE, VENKAYYA R, BROMBACHER F, RENNICK DM et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-2263.
23. HUMBERT M, DURHAM SR, KIMMITT P, POWELL N, ASSOUFI B, PFISTER R et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-665.
24. THORSTENSON KM, KHORUTS A. Generation of anergic and potentially immunoregulatory CD25 + CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001;167:188-195.
25. SUNDSTEDT A, O'NEILL EJ, NICOLSON KS, WRAITH DC. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 2003;170:1240-1248.
26. DIECKMANN D, PLOTTNER H, BERCHTOLD S, BERGER T, SCHULER G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001;193:1303-1310.
27. GROUX H, O'GARRA A, BIGLER M, ROULEAU M, ANTONENKO S, DE VRIES JE et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
28. BARRAT FJ, CUA DJ, BOONSTRA A, RICHARDS DF, CRAIN C, SAVELKOUL HF et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 2002;195:603-616.